We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stomach Wraps Effective in Treating Severe Acid Reflux

By HospiMedica International staff writers
Posted on 15 Apr 2010
Fundoplication may be more helpful than acid suppression tablets in the short to medium term treatment of severe gastro-esophageal reflux disease (GERD), according to a new study.

Researchers at the University of Aberdeen (United Kingdom) searched databases dating from 1966, conference abstracts, and reference lists from published trials, and contacted experts in the field for further unpublished material regarding trials comparing medical management of GERD with laparoscopic fundoplication surgery. More...
Two authors then independently extracted data from articles identified for inclusion, and assessed the methodological quality of eligible trials. The primary outcomes were health-related and GERD-specific quality of life (QOL), heartburn, regurgitation, and dysphagia. In all, four trials were included with a total of 1,232 randomized participants.

The results showed that there were statistically significant improvements in health-related QOL at three months and one year after surgery, compared to medical therapy. All four studies reported significant improvements in GERD-specific QOL after surgery compared to medical therapy, although data were not combined. The researchers found evidence to suggest that symptoms of heartburn, reflux, and bloating are improved after surgery compared to medical therapy, but a small proportion of participants have persistent postoperative dysphagia. Overall rates of postoperative complications were low, but surgery was not without risk and postoperative adverse events occurred, although they were uncommon. The costs of surgery were found to be considerably higher than the cost of medical management, although the data are based on the first year of treatment, and therefore the cost and side effects associated with long-term treatment of chronic GERD need to be considered. The study was published on March 17, 2010, in the Cochrane Database of Systematic Reviews.

"Previous research, prior to the development of keyhole surgery for GERD, has suggested that the benefits of surgery for GERD are not sustained over time, highlighting the importance for future keyhole fundoplication studies to include longer term follow-up,” said lead author Samantha Wileman, M.D., of the health services research unit. "We also need to know more about the clinical and cost implications of long term medication versus surgery.”

Related Links:

University of Aberdeen




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.